|
| 35652223 | Retraction: Pioglitazone, a PPARγ Agonist, Suppresses CYP19 Transcription: Evidence for Involvement of 15-Hydroxyprostaglandin Dehydrogenase and BRCA1. | Cancer Prev Res (Phila) | 2022 |
| 35652231 | Retraction: Obesity Is Associated With Inflammation and Elevated Aromatase Expression in the Mouse Mammary Gland. | Cancer Prev Res (Phila) | 2022 |
| 35652230 | Retraction: p53 Modulates Hsp90 ATPase Activity and Regulates Aryl Hydrocarbon Receptor Signaling. | Cancer Prevention Research | 2022 |
| 35652227 | Retraction: Dietary Polyphenols Suppress Elevated Levels of Proinflammatory Mediators and Aromatase in the Mammary Gland of Obese Mice. | Cancer Prev Res (Phila) | 2022 |
| 35652226 | Retraction: Caloric Restriction Reverses Obesity-Induced Mammary Gland Inflammation in Mice. | Cancer Prev Res (Phila) | 2022 |
| 34635689 | Author Correction: Patched1 haploinsufficiency severely impacts intermediary metabolism in the skin of Ptch1<sup>+/-</sup>/ODC transgenic mice. | Sci Rep | 2021 |
| 33947719 | Retraction: Increased Levels of COX-2 and Prostaglandin E2 Contribute to Elevated Aromatase Expression in Inflamed Breast Tissue of Obese Women. | Cancer Discov | 2021 |
| 32641470 | Naproxen chemoprevention promotes immune activation in Lynch syndrome colorectal mucosa. | Gut | 2021 |
| 31900371 | Withdrawal: p53 protein regulates Hsp90 ATPase activity and thereby Wnt signaling by modulating Aha1 expression. | Journal of Biological Chemistry | 2020 |
| 31258845 | ETHE1 overexpression promotes SIRT1 and PGC1α mediated aerobic glycolysis, oxidative phosphorylation, mitochondrial biogenesis and colorectal cancer. | Oncotarget | 2019 |
| 31506465 | Patched1 haploinsufficiency severely impacts intermediary metabolism in the skin of Ptch1<sup>+/-</sup>/ODC transgenic mice. | Sci Rep | 2019 |
| 30858923 | Global gene expression of histologically normal primary skin cells from BCNS subjects reveals "single-hit" effects that are influenced by rapamycin. | Oncotarget | 2019 |
| 30333917 | Erratum: Drug-Targeted Inhibition of Peroxisome Proliferator-Activated Receptor-gamma Enhances the Chemopreventive Effect of Anti-Estrogen Therapy. | Oncotarget | 2018 |
| 27682873 | Haploinsufficiency in tumor predisposition syndromes: altered genomic transcription in morphologically normal cells heterozygous for VHL or TSC mutation. | Oncotarget | 2017 |
| 28329421 | Naproxen Inhibits UVB-induced Basal Cell and Squamous Cell Carcinoma Development in Ptch1<sup>+/-</sup> /SKH-1 Hairless Mice. | Photochem Photobiol | 2017 |
| 28881566 | PPARs as determinants of the estrogen receptor lineage: use of synthetic lethality for the treatment of estrogen receptor-negative breast cancer. | Oncotarget | 2017 |
| 26577454 | Targeting mTOR and p53 Signaling Inhibits Muscle Invasive Bladder Cancer In Vivo. | Cancer Prevention Research | 2016 |
| 27293987 | Simultaneous targeting of 5-LOX-COX and ODC block NNK-induced lung adenoma progression to adenocarcinoma in A/J mice. | American Journal of Cancer Research (discontinued) | 2016 |
| 27074569 | Targeting cancer stem cells with p53 modulators. | Oncotarget | 2016 |
| 26693057 | TP53 modulating agent, CP-31398 enhances antitumor effects of ODC inhibitor in mouse model of urinary bladder transitional cell carcinoma. | American Journal of Cancer Research (discontinued) | 2015 |
| 25503930 | Sulindac reversal of 15-PGDH-mediated resistance to colon tumor chemoprevention with NSAIDs. | Carcinogenesis | 2015 |
| 26397133 | Early and delayed intervention with rapamycin prevents NNK-induced lung adenocarcinoma in A/J mice. | Oncology Reports | 2015 |
| 26294215 | Small-Molecule NSC59984 Restores p53 Pathway Signaling and Antitumor Effects against Colorectal Cancer via p73 Activation and Degradation of Mutant p53. | Cancer Research | 2015 |
| 26413810 | Shh and p50/Bcl3 signaling crosstalk drives pathogenesis of BCCs in Gorlin syndrome. | Oncotarget | 2015 |
| 26694476 | Detection of Exosomal miRNAs in the Plasma of Melanoma Patients. | Journal of Clinical Medicine | 2015 |
| 24736433 | p53 modulates Hsp90 ATPase activity and regulates aryl hydrocarbon receptor signaling. | Cancer Prevention Research | 2014 |
| 25405629 | Differential roles of ERα and ERβ in normal and neoplastic development in the mouse mammary gland. | PLoS ONE | 2014 |
| 24217507 | Erb-041, an estrogen receptor-β agonist, inhibits skin photocarcinogenesis in SKH-1 hairless mice by downregulating the WNT signaling pathway. | Cancer Prev Res (Phila) | 2014 |
| 24451373 | p53 protein regulates Hsp90 ATPase activity and thereby Wnt signaling by modulating Aha1 expression. | Journal of Biological Chemistry | 2014 |
| 24259003 | Isolation of circulating microRNAs from microvesicles found in human plasma. | Methods Mol Biol | 2014 |
| 24247721 | Prodigiosin rescues deficient p53 signaling and antitumor effects via upregulating p73 and disrupting its interaction with mutant p53. | Cancer Research | 2014 |
| 24758120 | Epithelial cell tumors of the hen reproductive tract. | Avian Diseases | 2014 |
| 24795386 | Chemoprevention of urothelial cell carcinoma growth and invasion by the dual COX-LOX inhibitor licofelone in UPII-SV40T transgenic mice. | Cancer Prevention Research | 2014 |
| 23371019 | Altered transcriptome signature of phenotypically normal skin fibroblasts heterozygous for CDKN2A in familial melanoma: relevance to early intervention. | Oncotarget | 2013 |
| 23001870 | PPARγ antagonist GW9662 induces functional estrogen receptor in mouse mammary organ culture: potential translational significance. | Molecular and Cellular Biochemistry | 2013 |
| 23771434 | Unbiased metabolite profiling indicates that a diminished thymidine pool is the underlying mechanism of colon cancer chemoprevention by alpha-difluoromethylornithine. | Cancer Discovery | 2013 |
| 23908596 | p53-stabilizing agent CP-31398 prevents growth and invasion of urothelial cancer of the bladder in transgenic UPII-SV40T mice. | Neoplasia | 2013 |
| 23907126 | Heritable one-hit events defining cancer prevention? | Cell Cycle | 2013 |
| 24260338 | Inhibiting cycloxygenase and ornithine decarboxylase by diclofenac and alpha-difluoromethylornithine blocks cutaneous SCCs by targeting Akt-ERK axis. | PLoS One | 2013 |
| 23811944 | PPARδ induces estrogen receptor-positive mammary neoplasia through an inflammatory and metabolic phenotype linked to mTOR activation. | Cancer Res | 2013 |
| 24027427 | Chemopreventive effects of the p53-modulating agents CP-31398 and Prima-1 in tobacco carcinogen-induced lung tumorigenesis in A/J mice. | Neoplasia | 2013 |
| 23936432 | Inhibition of proliferation and induction of autophagy by atorvastatin in PC3 prostate cancer cells correlate with downregulation of Bcl2 and upregulation of miR-182 and p21. | PLoS ONE | 2013 |
| 23839987 | Laccaic acid A is a direct, DNA-competitive inhibitor of DNA methyltransferase 1. | Journal of Biological Chemistry | 2013 |
| 24282520 | Polymorphisms in alcohol metabolism genes ADH1B and ALDH2, alcohol consumption and colorectal cancer. | PLoS ONE | 2013 |
| 23880231 | Dietary polyphenols suppress elevated levels of proinflammatory mediators and aromatase in the mammary gland of obese mice. | Cancer Prev Res (Phila) | 2013 |
| 24004147 | Immunodepletion plasma proteomics by tripleTOF 5600 and Orbitrap elite/LTQ-Orbitrap Velos/Q exactive mass spectrometers. | J Proteome Res | 2013 |
| 23274568 | Nitric oxide-releasing sulindac is a novel skin cancer chemopreventive agent for UVB-induced photocarcinogenesis. | Toxicol Appl Pharmacol | 2013 |
| 23147569 | Vorinostat, an HDAC inhibitor attenuates epidermoid squamous cell carcinoma growth by dampening mTOR signaling pathway in a human xenograft murine model. | Toxicol Appl Pharmacol | 2013 |
| 23430756 | Caloric restriction reverses obesity-induced mammary gland inflammation in mice. | Cancer Prev Res (Phila) | 2013 |
| 23665330 | Rapamycin targeting mTOR and hedgehog signaling pathways blocks human rhabdomyosarcoma growth in xenograft murine model. | Biochem Biophys Res Commun | 2013 |